The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine candidate, noting that it registered a 90% efficacy rate with no complications in its phase 3 study involving over 43K patients. Stocks took flight, bonds dropped, and small-caps and cyclicals
The pandemic is raging once again, with new record levels in case numbers across the US and EU. The spike is striking and proves the point for those who warned that cooler temperatures would mean a resurgence. The surge we have seen over the past week has set new records in many regions in terms
With the cold and flu season rapidly approaching, and two recent viral vaccine candidates for COVID-19 just put on pause, the global health system and the world economy both hang in the balance. And the X-Factor that will determine a great deal about how we come through this process is “Testing”. New data from the
Recent Comments